BRCA Panel Plus

What this laboratory test evaluates

BRCA Panel Plus
This test is crucial for understanding hereditary breast cancer. While 5-10% of breast cancer cases are inherited, genes known as BRCA1 and BRCA2 are responsible for 15-20% of these hereditary cases. Additionally, five other genes (CDH1, PALB2, PTEN, STK11, and TP53) are analyzed because they can explain another 3% to 4.5% of hereditary breast cancers. Knowing if these genes have any changes (mutations) can help assess the risk of developing breast cancer.

Who should consider this test?This test may be recommended for individuals with a family history of breast cancer, providing valuable information for managing their health.

What type of sample is required for this test?5 mL of whole blood collected in an EDTA (lavender-top) or ACD (yellow-top) tube.
A simple blood draw is needed.

Test Resources
https://education.questdiagnostics.com/faq/FAQ230

Additional test information

This test may be recommended for individuals with a family history of breast cancer, providing valuable information for managing their health.

Collection and processing

• Sample type: Whole blood
• Fasting: No
• Estimated laboratory processing: Results should be available in 2 – 5 business days after the sample is collected

How Sunridge uses laboratory information

Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.

Before requesting this test

Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.